Keyphrases
Beneficial Effects
100%
Signal Functions
100%
Receptor Activation
100%
Metabolic Signaling
100%
Mitochondrial Function
100%
Human Adipocytes
100%
Cannabinoid Receptor 2
100%
AMP-activated Protein Kinase
66%
Adipocyte
44%
AM1241
33%
Inducible Nitric Oxide Synthase
22%
Receptor Modulation
22%
Mitochondrial Oxidative Capacity
22%
Kinase Activation
11%
Phosphorylation
11%
Energy Sensor
11%
Glucose Uptake
11%
Cellular Energy
11%
Obesity
11%
Glucose Transport
11%
Mitochondrial Respiratory Function
11%
Therapeutic Target
11%
Nitric Oxide Production
11%
Immunoblotting
11%
Adiposity
11%
Receptor Agonist
11%
Acetyl-CoA Carboxylase
11%
2-Deoxyglucose Uptake
11%
Metabolic Function
11%
Endocannabinoid System
11%
Oxygen Consumption
11%
Extracellular Flux Analysis
11%
Metabolic Dysfunction
11%
Seahorse
11%
Synthase-dependent Pathway
11%
SR144528
11%
Medicine and Dentistry
Adipocyte
100%
Cannabinoid 2 Receptor
100%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
75%
3 (2 Iodo 5 Nitrobenzoyl) 1 (1 Methyl 2 Piperidinylmethyl)indole
37%
Glucose Uptake
25%
Nitric Oxide Synthase
25%
Receptor Modulation
25%
Acetyl-CoA
12%
Cell Energy
12%
Carboxylase
12%
Nitric Oxide
12%
Immunoblotting
12%
Endocannabinoid
12%
Obesity
12%
Cyclic AMP Dependent Protein Kinase
12%
Deoxyglucose
12%
Oxygen Consumption
12%
Cannabinoid 2 Receptor Agonist
12%
Biochemistry, Genetics and Molecular Biology
Adipocyte
100%
Cannabinoid
100%
AMP-activated Protein Kinase
66%
Glucose Transport
22%
Nitric Oxide Synthase
22%
Protein Kinase A
11%
Acetyl-CoA Carboxylase
11%
Cell Energy
11%
Nitric Oxide
11%
Receptor Agonists
11%
Oxygen Consumption
11%
Seahorse
11%
Extracellular Flux
11%
2-Deoxy-D-Glucose
11%
Immunoblotting
11%
Pharmacology, Toxicology and Pharmaceutical Science
Cannabinoid 2 Receptor
100%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
75%
Syndrome
37%
3 (2 Iodo 5 Nitrobenzoyl) 1 (1 Methyl 2 Piperidinylmethyl)indole
37%
Nitric Oxide Synthase
25%
Cyclic AMP Dependent Protein Kinase
12%
Western Blot
12%
Carboxylase
12%
Acetyl-CoA
12%
Nitric Oxide
12%
Endocannabinoid
12%
Obesity
12%
Deoxyglucose
12%
Cannabinoid 2 Receptor Agonist
12%
Seahorse
12%